Science
SCIENCE
Calorad® Scientific Information
Calorad® (Type II Oral Collagen Hydrolysat)

[ Home | Product Order | Order Product by FAX or Mail | Business Associate ]
[ Whats New | E-Mail | International Sales ]

  1. The New England Journal of Medicine evaluates genetic causes for obesity, page 1
  2. The Journal Science evaluates the effect of oral collagen in patients with rheumatoid arthritis, page 1
  3. The Journal Science evaluates the effect of oral collagen in patients with rheumatoid arthritis, page 2
  4. The Journal Science evaluates the effect of oral collagen in patients with rheumatoid arthritis, page 3
  5. The Journal Science evaluates the effect of oral collagen in patients with rheumatoid arthritis, page 4




More information to be posted later!


[ Home | Product Order | Order Product by FAX or Mail | Business Associate ]
[ Whats New | E-Mail | International Sales ]

Nutritional Supplement Advisor. February 17, 1999

NOTE: Always consult your physician or health care provider prior to undertaking any course of nutritional or alternative therapy. The information given herein is not intended as medical advice. We make NO claims concerning diagnosis, mitigation, treatment, prevention or cure of any disease with any nutritional supplement, including those represented within this site. We wish to point out, however, that in a landmark decision on Friday, January 15, 1999 which involved the the American Preventive Medical Association (APMA) and co-plaintiffs Durk Pearson and Sandy Shaw (authors of the best seller, "Life Extension, a Practical Scientific Approach") versus the United States, the US Court of Appeals for the District of Columbia Circuit ruled in favor of the plaintiffs and found the health claim rules imposed by the US Food and Drug Administration (FDA) unconstitutional and in violation of the Administrative Procedeure Act. The court instructed the FDA to define "significant scientific agreement" for health claims on dietary supplement labels, and instructed the FDA to allow the use of disclaimers on labels rather than to suppress these claims outright. The court further held that four FDA Final rules (prohibiting certain nutrient disease relationship claims) invalid under the first Amendment to the Constitution.